Immunology in neoplasia relating to diagnosis, therapy and transplantation. Immunosuppression and oncogenesis.
D000230:Adenocarcinoma / Q000139:chemically induced; D000818:Animals; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D002273:Carcinogens; D003348:Cortisone / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation; D008223:Lymphoma / Q000139:chemically induced; D008748:Methylcholanthrene; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000139:chemically induced / Q000209:etiology / Q000276:immunology* / Q000382:microbiology; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000276:immunology; D009858:Oncogenic Viruses; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D002273:Carcinogens; D007166:Immunosuppressive Agents; D008748:Methylcholanthrene; D001379:Azathioprine; D003348:Cortisone